Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine

NACompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Basic Science Study of the Mechanisms of Attentional Enhancement by Compounds Acting on the Nicotinic Receptor
Interventions
DRUG

Placebo patch & placebo capsule

On this test day, cognition is assessed after administration of a placebo patch and a placebo capsule.

DRUG

Placebo patch & galantamine capsule

On this test day, cognition is assessed after administration of a placebo patch and a galantamine capsule (4 mg p.o.).

DRUG

Nicotine patch & placebo capsule

On this test day, cognition is assessed after administration of a nicotine patch (7 mg/24 hrs) and a placebo capsule.

DRUG

Nicotine patch and galantamine capsule

On this test day, cognition is assessed after administration of a nicotine patch (7 mg/24 hrs) and a galantamine capsule (4 mg p.o.).

Trial Locations (1)

21228

University of Maryland School of Medicine, Maryland Psychiatric Research Center, Catonsville

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT02420327 - Low-Dose Galantamine to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine | Biotech Hunter | Biotech Hunter